Randomized controlled trials (RCTs) have traditionally served as the gold standard for generating evidence about medical interventions. However, RCTs have inherent limitations and may not reflect the use of medical products in the real world. Additionally, RCTs are expensive, time consuming, and cannot answer all questions about a product or intervention. Evidence generated from real-world use, such as real-world evidence (RWE) may provide valuable information, alongside RCTs, to inform medical product decision making. To explore the potential for using RWE in medical product decision making, the National Academies of Sciences, Engineering, and Medicine planned a three-part workshop series. The series was designed to examine the current system of evidence generation and its limitations, to identify when and why RWE may be an appropriate type of evidence on which to base decisions, to learn from successful initiatives that have incorporated RWE, and to describe barriers that prevent RWE from being used to its full potential. This publication summarizes the discussions from the entire workshop series.
Board on Health Sciences Policy & Health and Medicine Division
Examining the Impact of Real-World Evidence on Medical Product Development [EPUB ebook]
Proceedings of a Workshop Series
Examining the Impact of Real-World Evidence on Medical Product Development [EPUB ebook]
Proceedings of a Workshop Series
ซื้อ eBook เล่มนี้และรับฟรีอีก 1 เล่ม!
ภาษา อังกฤษ ● รูป EPUB ● หน้า 230 ● ISBN 9780309488327 ● บรรณาธิการ Amanda Wagner Gee & Benjamin Kahn ● สำนักพิมพ์ National Academies Press ● การตีพิมพ์ 2019 ● ที่สามารถดาวน์โหลดได้ 3 ครั้ง ● เงินตรา EUR ● ID 7145754 ● ป้องกันการคัดลอก Adobe DRM
ต้องใช้เครื่องอ่านหนังสืออิเล็กทรอนิกส์ที่มีความสามารถ DRM